Saturday, August 30th, 2025
Stock Profile: MDWD
MDWD Logo

MediWound Ltd. (MDWD)

Market: NASD | Currency: USD

Address: 42 Hayarkon Street

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and Show more




📈 MediWound Ltd. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2022 - $0.142857 - 2022-12-20 - Stock split
Total Amount for 2022: $0.142857


📅 Earnings & EPS History for MediWound Ltd.


DateReported EPS
2025-11-25 (estimated upcoming)-
2025-08-14-1.23
2025-05-21-0.07
2025-03-19-0.36
2024-11-26-0.98
2024-08-14-0.68
2024-05-29-1.05
2024-03-21-0.19
2023-11-21-0.24
2023-08-150.1
2023-05-30-0.44
2023-03-16-1.18
2022-11-15-0.91
2022-08-09-0.91
2022-05-17-0.84
2022-03-17-1.05
2021-11-16-0.84
2021-08-10-0.84
2021-05-05-0.7
2021-02-25-0.42
2020-11-10-0.49
2020-08-06-0.77
2020-05-20-0.63
2020-02-25-0.91
2019-11-14-0.77




📰 Related News & Research


No related articles found for "mediwound ltd".